Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.32B | 909.00M | 791.00M | 1.18B | 1.22B |
| Total Depreciation and Amortization | 649.00M | 672.00M | 672.00M | 657.00M | 679.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | 253.00M | -- |
| Total Other Non-Cash Items | -7.00M | 175.00M | 235.00M | -187.00M | 147.00M |
| Change in Net Operating Assets | 510.00M | -1.10B | -823.00M | 558.00M | -475.00M |
| Cash from Operations | 2.47B | 661.00M | 875.00M | 2.46B | 1.57B |
| Capital Expenditure | -346.00M | -461.00M | -354.00M | -378.00M | -332.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -52.00M | -22.00M | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -309.00M | 59.00M | -185.00M | -97.00M | 45.00M |
| Cash from Investing | -707.00M | -424.00M | -539.00M | -475.00M | -287.00M |
| Total Debt Issued | -311.00M | 821.00M | 500.00M | 1.35B | 276.00M |
| Total Debt Repaid | -- | -- | -- | -5.21B | -772.00M |
| Issuance of Common Stock | 57.00M | 72.00M | 77.00M | 99.00M | 56.00M |
| Repurchase of Common Stock | -132.00M | -226.00M | -152.00M | -97.00M | -71.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -917.00M | -918.00M | -918.00M | -905.00M | -904.00M |
| Other Financing Activities | -197.00M | 161.00M | -8.00M | -133.00M | -719.00M |
| Cash from Financing | -1.50B | -90.00M | -501.00M | -4.89B | -2.13B |
| Foreign Exchange rate Adjustments | 44.00M | -175.00M | -39.00M | -74.00M | 540.00M |
| Miscellaneous Cash Flow Adjustments | 1.00M | -- | -- | -- | 1.00M |
| Net Change in Cash | 312.00M | -28.00M | -204.00M | -2.98B | -306.00M |